• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JVI: Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitr

tetano

Editor, Senior Moderator
Published ahead of print 20 November 2013, doi: 10.1128/JVI.02681-13 JVI.02681-13

Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.

Yacine Abed,
Andr?s Pizzorno,
Xavier Bouhy,
Chantal Rh?aume and
Guy Boivin*

+ Author Affiliations

Research Center in Infectious Diseases of the CHUQ-CHUL and Laval University, Qu?bec City, QC, Canada.

ABSTRACT

Neuraminidase (NA) mutations conferring resistance to NA inhibitors (NAIs) generally compromise the fitness of influenza viruses. The only NAI-resistant virus that widely spread in the population, the A/Brisbane/59/2007 (H1N1) strain, contained permissive mutations that restored the detrimental effect caused by the H275Y change. Computational analysis predicted other permissive NA mutations for A(H1N1)pdm09 viruses. Herein, we investigated the effect of T289M and N369K mutations on the viral fitness of the A(H1N1)pdm09 H275Y variant. Recombinant A(H1N1)pdm09 wild-type (WT), H275Y, H275Y/T289M, H275Y/N369K and H275Y/V241I/N369K (a natural variant) NA mutants were generated by reverse genetics. Replication kinetics were performed using ST6GalI-MDCK cells. Virulence was assessed in C57BL/6 mice and contact transmission was evaluated in ferrets. The H275Y mutation significantly reduced viral titers during the first 12-36 h post-infection (PI) in vitro. Nevertheless, the WT and H275Y viruses induced comparable mortality rates, weight loss and lung titers in mice. The T289M mutation eliminated the detrimental effect caused by the H275Y change in vitro while causing greater weight loss and mortality in mice, with significantly higher lung viral titers on days 3 and 6 PI than the H275Y mutant. In index ferrets, the WT, H275Y, H275Y/T289M and H275Y/V241I/N369K recombinants induced comparable fever, weight loss and nasal wash viral titers (NWVTs). All tested viruses were transmitted at comparable rates in contact ferrets with the H275Y/V241I/N369K recombinant demonstrating higher NWVTs than the H275Y mutant. Permissive mutations may enhance the fitness of A(H1N1)pdm09 H275Y viruses in vitro and in vivo. The emergence of such variants should be carefully monitored.


http://jvi.asm.org/content/early/2013/11/15/JVI.02681-13.abstract
 
Back
Top Bottom